These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 34176369)

  • 21. Insights into the permeability of drugs and drug-like molecules from MI-QSAR and HQSAR studies.
    Shinde RN; Srikanth K; Sobhia ME
    J Mol Model; 2012 Mar; 18(3):947-62. PubMed ID: 21638045
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Web-Based Quantitative Structure-Activity Relationship Resources Facilitate Effective Drug Discovery.
    Wang YL; Li JY; Shi XX; Wang Z; Hao GF; Yang GF
    Top Curr Chem (Cham); 2021 Sep; 379(6):37. PubMed ID: 34554348
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pharmacokinetic properties and in silico ADME modeling in drug discovery.
    Honório KM; Moda TL; Andricopulo AD
    Med Chem; 2013 Mar; 9(2):163-76. PubMed ID: 23016542
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Considerations and recent advances in QSAR models for cytochrome P450-mediated drug metabolism prediction.
    Li H; Sun J; Fan X; Sui X; Zhang L; Wang Y; He Z
    J Comput Aided Mol Des; 2008 Nov; 22(11):843-55. PubMed ID: 18574695
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Two-dimensional (2D) in silico models for absorption, distribution, metabolism, excretion and toxicity (ADME/T) in drug discovery.
    Khakar PS
    Curr Top Med Chem; 2010; 10(1):116-26. PubMed ID: 19929825
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Novel Consensus Architecture To Improve Performance of Large-Scale Multitask Deep Learning QSAR Models.
    Zakharov AV; Zhao T; Nguyen DT; Peryea T; Sheils T; Yasgar A; Huang R; Southall N; Simeonov A
    J Chem Inf Model; 2019 Nov; 59(11):4613-4624. PubMed ID: 31584270
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Gaussian processes: a method for automatic QSAR modeling of ADME properties.
    Obrezanova O; Csanyi G; Gola JM; Segall MD
    J Chem Inf Model; 2007; 47(5):1847-57. PubMed ID: 17602549
    [TBL] [Abstract][Full Text] [Related]  

  • 28. QSAR-based permeability model for drug-like compounds.
    Gozalbes R; Jacewicz M; Annand R; Tsaioun K; Pineda-Lucena A
    Bioorg Med Chem; 2011 Apr; 19(8):2615-24. PubMed ID: 21458999
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prediction of drug intestinal absorption by new linear and non-linear QSPR.
    Talevi A; Goodarzi M; Ortiz EV; Duchowicz PR; Bellera CL; Pesce G; Castro EA; Bruno-Blanch LE
    Eur J Med Chem; 2011 Jan; 46(1):218-28. PubMed ID: 21112128
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Confident application of a global human liver microsomal activity QSAR.
    Stålring J; Sohlenius-Sternbeck AK; Terelius Y; Parkes K
    Future Med Chem; 2018 Jul; 10(13):1575-1588. PubMed ID: 29953260
    [TBL] [Abstract][Full Text] [Related]  

  • 31. CellMinerCDB: NCATS Is a Web-Based Portal Integrating Public Cancer Cell Line Databases for Pharmacogenomic Explorations.
    Reinhold WC; Wilson K; Elloumi F; Bradwell KR; Ceribelli M; Varma S; Wang Y; Duveau D; Menon N; Trepel J; Zhang X; Klumpp-Thomas C; Micheal S; Shinn P; Luna A; Thomas C; Pommier Y
    Cancer Res; 2023 Jun; 83(12):1941-1952. PubMed ID: 37140427
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Development of a Novel Quantitative Structure-Activity Relationship Model to Accurately Predict Pulmonary Absorption and Replace Routine Use of the Isolated Perfused Respiring Rat Lung Model.
    Edwards CD; Luscombe C; Eddershaw P; Hessel EM
    Pharm Res; 2016 Nov; 33(11):2604-16. PubMed ID: 27401409
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Evaluation of the GastroPlus™ Advanced Compartmental and Transit (ACAT) Model in Early Discovery.
    Gobeau N; Stringer R; De Buck S; Tuntland T; Faller B
    Pharm Res; 2016 Sep; 33(9):2126-39. PubMed ID: 27278908
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Integration of in silico and in vitro tools for scaffold optimization during drug discovery: predicting P-glycoprotein efflux.
    Desai PV; Sawada GA; Watson IA; Raub TJ
    Mol Pharm; 2013 Apr; 10(4):1249-61. PubMed ID: 23363443
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Tuning HERG out: antitarget QSAR models for drug development.
    Braga RC; Alves VM; Silva MF; Muratov E; Fourches D; Tropsha A; Andrade CH
    Curr Top Med Chem; 2014; 14(11):1399-415. PubMed ID: 24805060
    [TBL] [Abstract][Full Text] [Related]  

  • 36. In silico prediction of human oral absorption based on QSAR analyses of PAMPA permeability.
    Akamatsu M; Fujikawa M; Nakao K; Shimizu R
    Chem Biodivers; 2009 Nov; 6(11):1845-66. PubMed ID: 19937826
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Modeling Physico-Chemical ADMET Endpoints with Multitask Graph Convolutional Networks.
    Montanari F; Kuhnke L; Ter Laak A; Clevert DA
    Molecules; 2019 Dec; 25(1):. PubMed ID: 31877719
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Exploring Tunable Hyperparameters for Deep Neural Networks with Industrial ADME Data Sets.
    Zhou Y; Cahya S; Combs SA; Nicolaou CA; Wang J; Desai PV; Shen J
    J Chem Inf Model; 2019 Mar; 59(3):1005-1016. PubMed ID: 30586300
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Addressing Compound Reactivity and Aggregation Assay Interferences: Case Studies of Biochemical High-Throughput Screening Campaigns Benefiting from the National Institutes of Health
    Coussens NP; Auld DS; Thielman JR; Wagner BK; Dahlin JL
    SLAS Discov; 2021 Dec; 26(10):1280-1290. PubMed ID: 34218710
    [TBL] [Abstract][Full Text] [Related]  

  • 40. QSAR study on permeability of hydrophobic compounds with artificial membranes.
    Fujikawa M; Nakao K; Shimizu R; Akamatsu M
    Bioorg Med Chem; 2007 Jun; 15(11):3756-67. PubMed ID: 17418579
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.